Grants and Contracts Details
| Status | Finished |
|---|---|
| Effective start/end date | 12/2/14 → 6/30/16 |
Funding
- Kindex Pharmaceuticals: $481,152.00
Effects of KDT501 on Metabolic Features in Insulin Resistant Subjects
- Kern, Philip (PI)
| Status | Finished |
|---|---|
| Effective start/end date | 12/2/14 → 6/30/16 |